Norse Navigation Raises $151K to Advance Maritime Sensor Technology

Circio Holding ASA

Circio Holding ASA is a biotechnology company developing novel circular RNA expression technology for gene and cell therapy. Circio has established a unique circular RNA (circRNA) vector expression technology for next generation RNA, DNA and viral therapeutics. The proprietary circVec platform is based on a modular genetic construct designed for efficient biogenesis of multifunctional circRNA inside target cells. The circVec platform has applications in multiple therapeutic settings, including genetic medicine, cell therapy and chronic disease. It has demonstrated 75-fold increased RNA half-life and up to 50-fold enhanced protein expression vs conventional mRNA-based viral and non-viral vector systems, with the potential to become a new gold-standard gene expression technology. The circVec R&D activities are being conducted by the wholly owned subsidiary Circio AB in Stockholm, Sweden

Benford

Benford is a new-generation, tech-native audit firm. Instead of selling software to auditors, we are the auditor: we hold the licence, build the platform and employ the auditors who sign. Our proprietary engine, AuditOS, runs the statutory audit end to end, from a company's systems to the signed opinion. We are registered in Norway and running client audits today, with teams in London and Oslo, and backed by firstminute capital, Global Founders Capital, Sondo and the founders of HSO, Pennylane, Qonto and Amesto.